Publication

Video

Supplements and Featured Publications
Novel Emerging Therapies in Relapsed/Refractory AML
Volume 1
Issue 1

Dr. Sallman on the Role of Uproleselan in Targeting E-Selectin in AML

David Sallman, MD, discusses the role of uproleselan (GMI-1271) when utilized in acute myeloid leukemia.

David Sallman, MD, assistant member, Department of Malignant Hematology, Moffitt Cancer Center, discusses the role of uproleselan (GMI-1271) when utilized in acute myeloid leukemia (AML).

Uproleselan is a novel and specific inhibitor of E-selectin, which is vascular-adhesion molecule expressed on the vascular endothelium, Sallman says. In patients with AML, E-selectin can assist leukocytes in sticking to the vessel wall, sheltering the leukemic stem cells from chemotherapy and other agents in the bone-marrow microenvironment, Sallman explains. These cells typically do not divide, which is critical, since intensive chemotherapy targets cells that undergo active cell cycles, Sallman continues.

There are other potential bone-marrow microenvironment markers that may be targeted, though research with E-selectin is the farthest along, Sallman says. Moreover, additional research has demonstrated that E-selectin may help support and nurture leukemic stem cells, Sallman explains.

Overall, the goal is to utilize uproleselan in conjunction with intensive chemotherapy to target these specific leukemic stem cells that are a major driver of relapse, Sallman concludes.

Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center